314 related articles for article (PubMed ID: 30127297)
1. Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN).
Tobin D; Brevik-Andersen M; Qin Y; Innes JK; Calder PC
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30127297
[TBL] [Abstract][Full Text] [Related]
2. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
3. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
[TBL] [Abstract][Full Text] [Related]
4. Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial.
Cansanção K; Citelli M; Carvalho Leite N; López de Las Hazas MC; Dávalos A; Tavares do Carmo MDG; Peres WAF
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33147705
[TBL] [Abstract][Full Text] [Related]
5. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Calder PC; Byrne CD;
Contemp Clin Trials; 2014 Mar; 37(2):301-11. PubMed ID: 24556343
[TBL] [Abstract][Full Text] [Related]
6. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Hodson L; Moyses HE; Calder PC; Byrne CD;
Hepatology; 2014 Oct; 60(4):1211-21. PubMed ID: 25043514
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
[TBL] [Abstract][Full Text] [Related]
8. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
[TBL] [Abstract][Full Text] [Related]
9. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
[TBL] [Abstract][Full Text] [Related]
10. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
11. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
12. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
McDonnell SL; French CB; Baggerly CA; Harris WS
Nutr Res; 2019 Nov; 71():43-55. PubMed ID: 31757628
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing omega-3 fatty acid plasma levels after ingestion of emulsified and non-emulsified cod liver oil formulations.
Conus N; Burgher-Kennedy N; van den Berg F; Kaur Datta G
Curr Med Res Opin; 2019 Apr; 35(4):587-593. PubMed ID: 30106311
[TBL] [Abstract][Full Text] [Related]
15. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
17. Dietary fish oil supplementation affects serum fatty acid concentrations in horses.
O'Connor CI; Lawrence LM; Hayes SH
J Anim Sci; 2007 Sep; 85(9):2183-9. PubMed ID: 17504965
[TBL] [Abstract][Full Text] [Related]
18. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70 y: the OPTILIP study.
Sanders TA; Lewis F; Slaughter S; Griffin BA; Griffin M; Davies I; Millward DJ; Cooper JA; Miller GJ
Am J Clin Nutr; 2006 Sep; 84(3):513-22. PubMed ID: 16960164
[TBL] [Abstract][Full Text] [Related]
19. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients.
Hall TC; Bilku DK; Neal CP; Cooke J; Fisk HL; Calder PC; Dennison AR
Prostaglandins Leukot Essent Fatty Acids; 2016 Sep; 112():1-11. PubMed ID: 27637335
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
